On August 19, 2026, the Fifth Circuit vacated FDA’s marketing denial orders for NicQuid’s flavored electronic nicotine delivery systems and remanded back to the agency. The decision was a victory for WLF, which argued in an amicus brief that FDA’s actions violated NicQuid’s due-process rights and the Administrative Procedure Act.